Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
3 trials since 2013, 3 ongoing, by the sponsor of the products; see every authorized trial
An open-label, multicenter, phase 1 trial to evaluate the safety, pharmacokinetics, and antitumor activity of TLN-372…Oct 10, 2025 · Ongoing · TLN-372 / Pembrolizumab / Cetuximab / Itraconazole
An open-label, multicenter, phase 1 trial to evaluate the safety, pharmakonetics, and anti-tumour activity of TLN-121…Jun 20, 2025 · Ongoing · TLN-121 / Cyclophosphamide / Lunsumio (mosunetuzumab) / Columvi (glofitamab) / Gazyva (obinutuzumab) / Truxima (rituximab iv) / Mabthera (rituximab sc)
Phase 1b, randomized, dose optimization study to assess the anti-tumor activity, safety, and pharmacokinetics of…Oct 30, 2024 · Ongoing · TLN-254
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.